Source:http://linkedlifedata.com/resource/pubmed/id/11762554
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2001-12-13
|
pubmed:abstractText |
Immunosuppressive agents such as cyclosporine, tacrolimus, sirolimus, and corticosteroids are substrates for the transmembrane multidrug resistance pump P-glycoprotein (P-gp). Experience in oncologyhas suggested that chronic exposure to P-gp substrates induces upregulation of P-gp activity, which could result in resistance to immunosuppressive drugs. The authors investigated P-gp function in CD4+ and CD8+ T cells from the peripheral blood of solid organ transplant recipients (SOTX). Subjects included 14 stable SOTX (10 liver, 4 lung) and 16 healthy controls. Four-color flow cytometry was used to simultaneously measure intracellular concentration of the fluorescent P-gp substrate Rhodamine 123 (Rh123) and surface expression of CD45RO (nominal memory/effector), CD45RA (naive), and either CD4 or CD8. P-glycoprotein function was measured by a dye efflux assay in which activity was inferred from a decrease in Rh123 fluorescence. CD4+ and CD8+ T cells from patients and control subjects eliminated Rh123, and this activity was inhibited by verapamil, a known P-gp substrate. CD8+ T cells had greater P-gp activity than CD4+ cells, and naive and transitional T cells displayed greater activity than memory T cells. Activity was bimodal in CD8+ CD45RO+ T cells, with a subset of these cells expressing the greatest P-gp activity. Patient CD8+ naive and transitional T cells had upregulated P-gp activity compared to control subjects. We conclude that (1) P-gp activityis significantly upregulated in specific T-cell subsets (CD8+/CD45RA+) in the peripheral blood of SOTX, and (2) the bimodal nature of P-gp response in CD8+ T cells complicates analysis of the effect of chronic administration of P-gp substrates to SOTX.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0091-2700
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1271-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11762554-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11762554-CD8-Positive T-Lymphocytes,
pubmed-meshheading:11762554-Cross-Sectional Studies,
pubmed-meshheading:11762554-Flow Cytometry,
pubmed-meshheading:11762554-Humans,
pubmed-meshheading:11762554-Organ Transplantation,
pubmed-meshheading:11762554-P-Glycoprotein,
pubmed-meshheading:11762554-T-Lymphocyte Subsets
|
pubmed:year |
2001
|
pubmed:articleTitle |
P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients.
|
pubmed:affiliation |
Department of Medicine, School of Pharmacy, University of Pittsburgh, Pennsylvania 15213, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|